Sertoli cell dedifferentiation in human cryptorchidism and gender reassignment shows similarities between fetal environmental and adult medical treatment estrogen and antiandrogen exposure

Reproductive Toxicology

Volumn 42, Issue , 2013, Pages 172-179

  Nistal, Manuel ^a   Gonzalez Peramato, Pilar ^a   De Miguel, Maria P ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cryptorchidism; Estrogen; Gender identity reassignment; Sertoli cells; Testicular dysgenesis syndrome

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; CELL MARKER; ESTROGEN; M2A ANTIGEN; MUELLERIAN INHIBITING FACTOR; SIALOGLYCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DEDIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CRYPTORCHISM; DRUG EXPOSURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; SERTOLI CELL; SEX REASSIGNMENT;

CRYPTORCHIDISM; ESTROGEN; GENDER IDENTITY REASSIGNMENT; SERTOLI CELLS; TESTICULAR DYSGENESIS SYNDROME;

ADULT; ANDROGEN ANTAGONISTS; ANTI-MULLERIAN HORMONE; CALBINDIN 2; CELL DEDIFFERENTIATION; CRYPTORCHIDISM; ESTROGENS; FEMALE; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; MIDDLE AGED; PREGNANCY; SEMINIFEROUS TUBULES; SERTOLI CELLS; SEX REASSIGNMENT PROCEDURES; WT1 PROTEINS; YOUNG ADULT;

EID: 84884567337     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.08.009     Document Type: Article

References (76)

1. Richiardi L., Akre O., Montgomery S.M., Lambe M., Kvist U., et al. Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J Natl Cancer Inst 2004, 96:145-147.
2. Delbes G., Levacher C., Habert R. Estrogen effects on fetal and neonatal testicular development. Reproduction 2006, 132:527-538.
3. Serrano T., Chevrier C., Multigner L., Cordier S., Jegou B. International geographic correlation study of the prevalence of disorders of male reproductive health. Hum Reprod 2013, 28:1974-1986.
4. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001, 16:972-978.
5. Sharpe R.M., McKinnell C., Kivlin C., Fisher J.S. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 2003, 125:769-784.
6. Cain M.P., Kramer S.A., Tindall D.J., Husmann D.A. Expression of androgen receptor protein within the lumbar spinal cord during ontologic development and following antiandrogen induced cryptorchidism. J Urol 1994, 152:766-769.
7. Tanyel F.C., Erdem S., Buyukpamukcu N., Tan E. Cremaster muscles obtained from boys with an undescended testis show significant neurological changes. BJU Int 2000, 85:116-119.
8. Lehmann K.P., Phillips S., Sar M., Foster P.M., Gaido K.W. Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicol Sci 2004, 81:60-68.
9. Fisher J.S., Macpherson S., Marchetti N., Sharpe R.M. Human testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. Hum Reprod 2003, 18:1383-1394.
10. Bernstein L., Pike M.C., Depue R.H., Ross R.K., Moore J.W., et al. Maternal hormone levels in early gestation of cryptorchid males: a case-control study. Br J Cancer 1988, 58:379-381.
11. Delbes G., Levacher C., Duquenne C., Racine C., Pakarinen P., et al. Endogenous estrogens inhibit mouse fetal Leydig cell development via estrogen receptor alpha. Endocrinology 2005, 146:2454-2461.
12. Hutson J.M., Williams M.P., Fallat M.E., Attah A. Testicular descent: new insights into its hormonal control. Oxf Rev Reprod Biol 1990, 12:1-56.
13. Spencer J.R. The endocrinology of testicular descent. AUA Update Series Lesson 1994, vol. 12:94-99.
14. Staub C., Rauch M., Ferriere F., Trepos M., Dorval-Coiffec I., et al. Expression of estrogen receptor ESR1 and its 46-kDa variant in the gubernaculum testis. Biol Reprod 2005, 73:703-712.
15. Glaze G.M. Diethylstilbestrol exposure in utero: review of literature. J Am Osteopath Assoc 1984, 83:435-438.
16. Miao M., Yuan W., He Y., Zhou Z., Wang J., et al. In utero exposure to bisphenol-A and anogenital distance of male offspring. Birth Defects Res A Clin Mol Teratol 2011, 91:867-872.
17. Storgaard L., Bonde J.P., Olsen J. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reprod Toxicol 2006, 21:4-15.
18. Lague E., Tremblay J.J. Estradiol represses insulin-like 3 expression and promoter activity in MA-10 Leydig cells. Toxicology 2009, 258:101-105.
19. D'Souza R., Pathak S., Upadhyay R., Gaonkar R., D'Souza S., et al. Disruption of tubulobulbar complex by high intratesticular estrogens leading to failed spermiation. Endocrinology 2009, 150:1861-1869.
20. Nonomura K., Fujieda K., Sakakibara N., Terasawa K., Matsuno T., et al. Pituitary and gonadal function in prepubertal boys with hypospadias. J Urol 1984, 132:595-598.
21. Shima H., Ikoma F., Yabumoto H., Mori M., Satoh Y., et al. Gonadotropin and testosterone response in prepubertal boys with hypospadias. J Urol 1986, 135:539-542.
22. Gearhart J.P., Donohoue P.A., Brown T.R., Walsh P.C., Berkovitz G.D. Endocrine evaluation of adults with mild hypospadias. J Urol 1990, 144:274-277.
23. Akre O., Richiardi L. Does a testicular dysgenesis syndrome exist?. Hum Reprod 2009, 24:2053-2060.
24. Iwatsuki S., Kojima Y., Mizuno K., Kamisawa H., Umemoto Y., et al. Endocrine assessment of prepubertal boys with a history of cryptorchidism and/or hypospadias: a pilot study. J Urol 2011, 185:2444-2450.
25. Hoei-Hansen C.E., Holm M., Rajpert-De Meyts E., Skakkebaek N.E. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 2003, 200:370-374.
26. Main K.M., Skakkebaek N.E., Virtanen H.E., Toppari J. Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 2010, 24:279-289.
27. Sohval A.R. Testicular dysgenesis in relation to neoplasm of the testicle. J Urol 1956, 75:285-291.
28. Hedinger C., Plattner D. Dysgenetic, so-called hypoplastic zones in retained and normal bilaterally descended testes. Pathol Microbiol (Basel) 1961, 24:227-233.
29. Plattner D. Hypoplastic and germinal epithelium-free zones in bilaterally descended testes as a sign of a partial dysgenesis. Virchows Arch Pathol Anat Physiol Klin Med 1962, 335:598-616.
30. Huber R., Weber E., Hedinger C. On the microscopic anatomy of the so-called hypoplastic zones of the normal descended testis. Virchows Arch A Pathol Pathol Anat 1968, 344:47-53.
31. Hedinger C.E., Huber R., Weber E. Frequency of so-called hypoplastic or dysgenetic zones in scrotal and otherwise normal human tests. Virchows Arch Pathol Anat Physiol Klin Med 1967, 342:165-168.
32. Nistal M., Paniagua R., Abaurrea M.A., Santamaria L. Hyperplasia and the immature appearance of Sertoli cells in primary testicular disorders. Hum Pathol 1982, 13:3-12.
33. Kliesch S., Behre H.M., Hertle L., Bergmann M. Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes. J Urol 1998, 160:1894-1898.
34. Nistal M., Gonzalez-Peramato P., Regadera J., Serrano A., Tarin V., et al. Primary testicular lesions are associated with testicular germ cell tumors of adult men. Am J Surg Pathol 2006, 30:1260-1268.
35. Pentikainen V., Erkkila K., Suomalainen L., Parvinen M., Dunkel L. Estradiol acts as a germ cell survival factor in the human testis in vitro. J Clin Endocrinol Metab 2000, 85:2057-2067.
36. Kula K., Walczak-Jedrzejowska R., Slowikowska-Hilczer J., Oszukowska E. Estradiol enhances the stimulatory effect of FSH on testicular maturation and contributes to precocious initiation of spermatogenesis. Mol Cell Endocrinol 2001, 178:89-97.
37. Carreau S., Wolczynski S., Galeraud-Denis I. Aromatase, oestrogens, human male reproduction. Philos Trans R Soc Lond B: Biol Sci 2010, 365:1571-1579.
38. Tanaka M., Nakaya S., Katayama M., Leffers H., Nozawa S., et al. Effect of prenatal exposure to bisphenol A on the serum testosterone concentration of rats at birth. Hum Exp Toxicol 2006, 25:369-373.
39. Thuillier R., Manku G., Wang Y., Culty M. Changes in MAPK pathway in neonatal and adult testis following fetal estrogen exposure and effects on rat testicular cells. Microsc Res Techn 2009, 72:773-786.
40. Hu G.X., Lian Q.Q., Ge R.S., Hardy D.O., Li X.K. Phthalate-induced testicular dysgenesis syndrome: Leydig cell influence. Trends Endocrinol Metab 2009, 20:139-145.
41. Klinefelter G.R., Laskey J.W., Winnik W.M., Suarez J.D., Roberts N.L., et al. Novel molecular targets associated with testicular dysgenesis induced by gestational exposure to diethylhexyl phthalate in the rat: a role for estradiol. Reproduction 2012, 144:747-761.
42. N'Tumba-Byn T., Moison D., Lacroix M., Lecureuil C., Lesage L., et al. Differential effects of bisphenol A and diethylstilbestrol on human, rat and mouse fetal leydig cell function. PLoS ONE 2012, 7:e51579.
43. Yuan K., Zhao B., Li X.W., Hu G.X., Su Y., et al. Effects of phthalates on 3beta-hydroxysteroid dehydrogenase and 17beta-hydroxysteroid dehydrogenase 3 activities in human and rat testes. Chem Biol Interact 2012, 195:180-188.
44. Clewell R.A., Thomas A., Willson G., Creasy D.M., Andersen M.E. A dose response study to assess effects after dietary administration of diisononyl phthalate (DINP) in gestation and lactation on male rat sexual development. Reprod Toxicol 2013, 35:70-80.
45. Ivell R., Heng K., Nicholson H., Anand-Ivell R. Brief maternal exposure of rats to the xenobiotics dibutyl phthalate or diethylstilbestrol alters adult-type Leydig cell development in male offspring. Asian J Androl 2013, 15:261-268.
46. Strohsnitter W.C., Noller K.L., Hoover R.N., Robboy S.J., Palmer J.R., et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 2001, 93:545-551.
47. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse R.L., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005, 113:1056-1061.
48. Upadhyay R.D., Kumar A.V., Sonawane S., Gaonkar R., Balasinor N.H. Estrogen effects on actin cytoskeletal and endocytic proteins associated with tubulobulbar complex disruption in rat testes. Reprod Sci 2013.
49. Akingbemi B.T., Sottas C.M., Koulova A.I., Klinefelter G.R., Hardy M.P. Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 2004, 145:592-603.
50. vom Saal F.S., Cooke P.S., Buchanan D.L., Palanza P., Thayer K.A., et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 1998, 14:239-260.
51. Safe S. Clinical correlates of environmental endocrine disruptors. Trends Endocrinol Metab 2005, 16:139-144.
52. Meeker J.D., Calafat A.M., Hauser R. Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic. Environ Sci Technol 2010, 44:1458-1463.
53. Mendiola J., Jorgensen N., Andersson A.M., Calafat A.M., Ye X., et al. Are environmental levels of bisphenol a associated with reproductive function in fertile men?. Environ Health Perspect 2010, 118:1286-1291.
54. De La Balze F.A., Mancini R.E., Bur G.E., Irazu J. Morphologic and histochemical changes produced by estrogens on adult human testes. Fertil Steril 1954, 5:421-436.
55. Lu C.C., Steinberger A. Effects of estrogen on human seminiferous tubules: light and electron microscopic analysis. Am J Anat 1978, 153:1-13.
56. Payer A.F., Meyer W.J., Walker P.A. The ultrastructural response of human Leydig cells to exogenous estrogens. Andrologia 1979, 11:423-436.
57. Schulze C. Sertoli cells and Leydig cells in man. Adv Anat Embryol Cell Biol 1984, 88:1-104.
58. Schulze C. Response of the human testis to long-term estrogen treatment: morphology of Sertoli cells Leydig cells and spermatogonial stem cells. Cell Tissue Res 1988, 251:31-43.
59. Nistal M., Pastrian L.G., Gonzalez-Peramato P., De Miguel M.P. Inhibin bodies: a new marker for immature Sertoli cells. Histopathology 2011, 58:1019-1027.
60. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., et al. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol. A Environ Health Perspect 2010, 118:1055-1070.
61. Sikka S.C., Wang R. Endocrine disruptors, estrogenic effects on male reproductive axis. Asian J Androl 2008, 10:134-145.
62. Nistal M., Gonzalez-Peramato P., De Miguel M.P. Immunodetection of inhibin in the human testis and epididymis during normal development and in non-tumoural testicular lesions. Reprod Fertil Dev 2010, 22:558-563.
63. Becerra-Fernández A., Pérez-Lópezb G., Lucio M.J., Asenjo N., Rodríguez-Molina J.M., Fernández-Serrano M.J., et al. Valoración del tratamiento hormonal cruzado en transexuales: experiencia de una unidad de trastornos de identidad de género. Rev Int Androl 2009, 7.
64. Steger K., Rey R., Louis F., Kliesch S., Behre H.M., et al. Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis. Hum Reprod 1999, 14:136-143.
65. Brehm R., Rey R., Kliesch S., Steger K., Marks A., et al. Mitotic activity of Sertoli cells in adult human testis: an immunohistochemical study to characterize Sertoli cells in testicular cords from patients showing testicular dysgenesis syndrome. Anat Embryol (Berlin) 2006, 211:223-236.
66. Franke F.E., Pauls K., Rey R., Marks A., Bergmann M., et al. Differentiation markers of Sertoli cells and germ cells in fetal and early postnatal human testis. Anat Embryol (Berlin) 2004, 209:169-177.
67. Chemes H.E., Rey R.A., Nistal M., Regadera J., Musse M., et al. Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab 2008, 93:4408-4412.
68. Bar-Shira Maymon B., Yavetz H., Yogev L., Kleiman S.E., Lifschitz-Mercer B., et al. Detection of calretinin expression in abnormal immature Sertoli cells in non-obstructive azoospermia. Acta Histochem 2005, 107:105-112.
69. Rajpert-De Meyts E., Jorgensen N., Graem N., Muller J., Cate R.L., et al. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999, 84:3836-3844.
70. Schutz W. Histology of the human testes following hormone therapy of prostate carcinoma. Langenbecks Arch Klin Chir Ver Dtsch Z Chir 1952, 271:65-76.
71. Mihalache G., Adomnicai G., Adomnicai M., Iancu I., Mihalache C. Testicular changes during estrogen therapy of prostatic cancer. Rev Med Chir Soc Med Nat Iasi 1986, 90:343-345.
72. Wortsman J., Hamidinia A., Winters S.J. Hypogonadism following long-term treatment with diethylstilbestrol. Am J Med Sci 1989, 297:365-368.
73. Lottrup G., Jorgensen A., Nielsen J.E., Jorgensen N., Duno M., et al. Identification of a novel androgen receptor mutation in a family with multiple components compatible with the testicular dysgenesis syndrome. J Clin Endocrinol Metab 2013, 98:2223-2229.
74. Perobelli J.E., Patrao M.T., Fernandez C.D., Sanabria M., Klinefelter G.R., et al. Androgen deprivation from pre-puberty to peripuberty interferes in proteins expression in pubertal and adult rat epididymis. Reprod Toxicol 2013, 38:65-71.
75. Sharpe R.M., Franks S. Environment, lifestyle and infertility--an inter-generational issue. Nat Cell Biol 2002, 4(Suppl.):s33-s40.
76. Fielden M.R., Samy S.M., Chou K.C., Zacharewski T.R. Effect of human dietary exposure levels of genistein during gestation and lactation on long-term reproductive development and sperm quality in mice. Food Chem Toxicol 2003, 41:447-454.